DHRS9 Is a Stable Marker of Human Regulatory Macrophages. Issue 11 (November 2017)
- Record Type:
- Journal Article
- Title:
- DHRS9 Is a Stable Marker of Human Regulatory Macrophages. Issue 11 (November 2017)
- Main Title:
- DHRS9 Is a Stable Marker of Human Regulatory Macrophages
- Authors:
- Riquelme, Paloma
Amodio, Giada
Macedo, Camila
Moreau, Aurelie
Obermajer, Nataša
Brochhausen, Christoph
Ahrens, Norbert
Kekarainen, Tuija
Fändrich, Fred
Cuturi, Cristina
Gregori, Silvia
Metes, Diana
Schlitt, Hans J.
Thomson, Angus W.
Geissler, Edward K.
Hutchinson, James A. - Abstract:
- Abstract : Background: The human regulatory macrophage (Mreg) has emerged as a promising cell type for use as a cell-based adjunct immunosuppressive therapy in solid organ transplant recipients. In this brief report, dehydrogenase/reductase 9 (DHRS9) is identified as a robust marker of human Mregs. Methods: The cognate antigen of a mouse monoclonal antibody raised against human Mregs was identified as DHRS9 by immunoprecipitation and MALDI-MS sequencing. Expression of DHRS9 within a panel of monocyte-derived macrophages was investigated by quantitative PCR, immunoblotting and flow cytometry. Results: DHRS9 expression discriminated human Mregs from a panel of in vitro derived macrophages in other polarisation states. Likewise, DHRS9 expression distinguished Mregs from a variety of human monocyte-derived tolerogenic antigen-presenting cells in current development as cell-based immunotherapies, including Tol-DC, Rapa-DC, DC-10, and PGE2 -induced myeloid-derived suppressor cells. A subpopulation of DHRS9-expressing human splenic macrophages was identified by immunohistochemistry. Expression of DHRS9 was acquired gradually during in vitro development of human Mregs from CD14 + monocytes and was further enhanced by IFN-γ treatment on day 6 of culture. Stimulating Mregs with 100 ng/mL lipopolysaccharide for 24 hours did not extinguish DHRS9 expression. Dhrs9 was not an informative marker of mouse Mregs. Conclusion: DHRS9 is a specific and stable marker of human Mregs. Abstract : AAbstract : Background: The human regulatory macrophage (Mreg) has emerged as a promising cell type for use as a cell-based adjunct immunosuppressive therapy in solid organ transplant recipients. In this brief report, dehydrogenase/reductase 9 (DHRS9) is identified as a robust marker of human Mregs. Methods: The cognate antigen of a mouse monoclonal antibody raised against human Mregs was identified as DHRS9 by immunoprecipitation and MALDI-MS sequencing. Expression of DHRS9 within a panel of monocyte-derived macrophages was investigated by quantitative PCR, immunoblotting and flow cytometry. Results: DHRS9 expression discriminated human Mregs from a panel of in vitro derived macrophages in other polarisation states. Likewise, DHRS9 expression distinguished Mregs from a variety of human monocyte-derived tolerogenic antigen-presenting cells in current development as cell-based immunotherapies, including Tol-DC, Rapa-DC, DC-10, and PGE2 -induced myeloid-derived suppressor cells. A subpopulation of DHRS9-expressing human splenic macrophages was identified by immunohistochemistry. Expression of DHRS9 was acquired gradually during in vitro development of human Mregs from CD14 + monocytes and was further enhanced by IFN-γ treatment on day 6 of culture. Stimulating Mregs with 100 ng/mL lipopolysaccharide for 24 hours did not extinguish DHRS9 expression. Dhrs9 was not an informative marker of mouse Mregs. Conclusion: DHRS9 is a specific and stable marker of human Mregs. Abstract : A brief definitive report that dehydrogenase/reductase 9 (DHRS9) is a robust marker of human, but not mouse, Mregs. … (more)
- Is Part Of:
- Transplantation. Volume 101:Issue 11(2017)
- Journal:
- Transplantation
- Issue:
- Volume 101:Issue 11(2017)
- Issue Display:
- Volume 101, Issue 11 (2017)
- Year:
- 2017
- Volume:
- 101
- Issue:
- 11
- Issue Sort Value:
- 2017-0101-0011-0000
- Page Start:
- Page End:
- Publication Date:
- 2017-11
- Subjects:
- Transplantation of organs, tissues, etc -- Periodicals
Transplantation immunology -- Periodicals
617.95 - Journal URLs:
- http://journals.lww.com/pages/default.aspx ↗
- DOI:
- 10.1097/TP.0000000000001814 ↗
- Languages:
- English
- ISSNs:
- 0041-1337
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9024.990000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 8316.xml